2026-23668NoticeWallet

FDA Explains How Medical Device Clearances Change Hands

Published Date: 11/20/2026

Notice

Summary

The FDA just released clear answers about how companies can transfer their 510(k) medical device approvals to new owners. This helps businesses understand the rules when selling or buying these clearances, making the process smoother and more predictable. The guidance is effective immediately and doesn’t add new costs but helps avoid confusion and delays.

Analyzed Economic Effects

6 provisions identified: 2 benefits, 4 costs, 0 mixed.

Noncompliance can render a device adulterated or misbranded

If you fail to register, list, update GUDID information, or submit a required marketing application, FDA states your device may be considered adulterated and/or misbranded under the Federal Food, Drug, and Cosmetic Act.

New 510(k) holder must register and list

If you buy or receive a 510(k) clearance and you are engaged in manufacturing or other listed operations, you must register and list the device in FDA’s electronic registration and listing system. You must register within 30 days after entering into those operations and include the FDA-assigned cleared 510(k) premarket submission number when you submit your device listing.

Significant changes trigger a new 510(k)

If the new 510(k) holder significantly changes the device’s design, components, manufacturing method, or intended use, the new holder must generally submit a new 510(k). After clearance of that new 510(k), the holder must list the device using the new FDA-assigned premarket submission number.

Labeler must update GUDID promptly

If the labeler information (for example, the name of the labeler) changes when a 510(k) clearance transfers, the labeler must submit an update to the Global Unique Device Identification Database (GUDID). The update must be submitted no later than the date the device is first labeled with the changed information, or within 10 business days of the change if the information does not appear on the label.

Guidance adds no new paperwork collections

FDA says this guidance contains no new collection of information under the Paperwork Reduction Act and instead refers to previously approved information collections (for example, OMB control numbers 0910-0120 and 0910-0625).

Guidance clarifies transfer rules and terminology

FDA revised the guidance after public comments to clarify terminology and further explain 510(k) holder requirements related to the sale or transfer of a 510(k) clearance. The guidance provides Frequently Asked Questions to explain when a new 510(k) is needed and how to list transferred devices.

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
11/20/2026

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register